63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details
臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05685420 (ClinicalTrials.gov) | January 23, 2023 | 6/1/2023 | Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia | Extension Study of Herombopag in Children and Adolescents With Chronic Primary Immune Thrombocytopenia | Immune Thrombocytopenia | Drug: Herombopag | Jiangsu HengRui Medicine Co., Ltd. | NULL | Not yet recruiting | 6 Years | 17 Years | All | 117 | Phase 3 | NULL |